As of August 28, 2026, Quantum BioPharma Ltd. (QNTM) has a DilutionWatch DilutionScore of 44/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Quantum BioPharma Ltd. has a market capitalization of $43.89M, 72 shares outstanding, 26 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for QNTM.
Market Data
Market Cap$43.89M
Shares Outstanding72
FloatN/A
Cash$4.56M
Debt$870.1K
Short InterestN/A
Institutional Holdings
QoQ: ↑ 100.1% shares (2026Q1 vs prior)
26 institutional holders · 257.1K shares
#1
AdvisorShares Investments LLC
108.6K shares
#2
Platform Technology Partners
41.1K shares
#3
JANE STREET GROUP, LLC
31.5K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest303.8K
Days to Cover3.5
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track QNTM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking QNTM — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.
More Research for QNTM
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.